LGHT vs. YCS
LGHT (Langar Global HealthTech ETF) and YCS (ProShares UltraShort Yen) are both exchange-traded funds - LGHT is a Health & Biotech Equities fund actively managed by Langar, while YCS is a Leveraged Currency fund tracking the USD/JPY Exchange Rate (-200%). LGHT is actively managed, while YCS is passively managed. Over the past year, LGHT returned -11.86% vs 21.34% for YCS. Their -0.13 correlation means they have often moved in opposite directions in the past. LGHT charges 0.85%/yr vs 1.00%/yr for YCS.
Performance
LGHT vs. YCS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LGHT achieves a -11.21% return, which is significantly lower than YCS's 4.11% return.
LGHT
- 1D
- 2.48%
- 1M
- -1.15%
- 6M
- -9.79%
- YTD
- -11.21%
- 1Y
- -11.86%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -5.07%
YCS
- 1D
- -2.97%
- 1M
- -5.17%
- 6M
- 5.08%
- YTD
- 4.11%
- 1Y
- 21.34%
- 3Y*
- 16.96%
- 5Y*
- 22.90%
- 10Y*
- 13.21%
- ALL TIME*
- 6.26%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $39.55K | $23.01K | $17.27K | |
| $2.37M | $2.29M | $1.56M |
LGHT vs. YCS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LGHT Langar Global HealthTech ETF | -11.21% | -1.66% | 0.23% |
YCS ProShares UltraShort Yen | 4.11% | 9.04% | 28.63% |
Correlation
The correlation between LGHT and YCS is -0.26, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 10, 2024 | -0.13 |
The correlation between LGHT and YCS shifts across timeframes, from -0.26 (1 year) to -0.13 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LGHT vs. YCS — Risk / Return Rank
LGHT
YCS
LGHT vs. YCS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Langar Global HealthTech ETF (LGHT) and ProShares UltraShort Yen (YCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LGHT | YCS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.89 | ||
| Sortino ratioReturn per unit of downside risk | -2.42 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.26 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.47 | 2.53 | -2.99 |
| Martin ratioReturn relative to average drawdown | -0.87 | 9.53 | -10.40 |
Loading charts...
Drawdowns
LGHT vs. YCS - Drawdown Comparison
The maximum LGHT drawdown since its inception was -28.60%, smaller than the maximum YCS drawdown of -49.56%. Use the drawdown chart below to compare losses from any high point for LGHT and YCS.
Loading charts...
Drawdown Indicators
| LGHT | YCS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.60% | -49.56% | +20.96% |
Max Drawdown (1Y)Largest decline over 1 year | -25.57% | -8.48% | -17.09% |
Max Drawdown (3Y)Largest decline over 3 years | — | -23.05% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.32% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.32% | — |
Current DrawdownCurrent decline from peak | -20.17% | -8.48% | -11.69% |
Average DrawdownAverage peak-to-trough decline | -8.58% | -19.75% | +11.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.65% | 2.24% | +11.41% |
Volatility
LGHT vs. YCS - Volatility Comparison
Langar Global HealthTech ETF (LGHT) has a higher volatility of 8.16% compared to ProShares UltraShort Yen (YCS) at 5.88%. This indicates that LGHT's price experiences larger fluctuations and is considered to be riskier than YCS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LGHT | YCS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.16% | 5.88% | +2.28% |
Volatility (6M)Calculated over the trailing 6-month period | 16.64% | 11.84% | +4.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.32% | 16.43% | +3.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.47% | 21.21% | -1.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.47% | 18.61% | +0.86% |
LGHT vs. YCS - Expense Ratio Comparison
LGHT has a 0.85% expense ratio, which is lower than YCS's 1.00% expense ratio.
Dividends
LGHT vs. YCS - Dividend Comparison
Neither LGHT nor YCS has paid dividends to shareholders.
Frequently Asked Questions
LGHT and YCS have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LGHT has higher volatility (8.16%) compared to YCS (5.88%). In terms of maximum drawdown, LGHT dropped -28.60% vs YCS's -49.56%.
On 1-year performance, YCS leads with 21.34% vs -11.86% for LGHT. On fees, LGHT is cheaper at 0.85% per year. On volatility, YCS has been the lower-risk option at 5.88%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, YCS has performed better with a 21.34% return vs -11.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
LGHT is cheaper with a 0.85% expense ratio, compared with 1.00% for YCS.
LGHT and YCS have nearly identical dividend yields, around 0.00%.
LGHT is categorized as Health & Biotech Equities, while YCS is Leveraged Currency. They also come from different issuers: Langar and ProShares. Their fees differ too: 0.85% for LGHT and 1.00% for YCS.
YCS currently has the higher Sharpe Ratio (1.31 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LGHT and YCS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer